Interleukin-32 Expression in the Pancreas
Open Access
- 1 June 2009
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (26) , 17868-17876
- https://doi.org/10.1074/jbc.m900368200
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Identification of the most active interleukin‐32 isoformImmunology, 2009
- Proapoptotic Bad and Bid Protein Expression Predict Survival in Stages II and III Colon CancersClinical Cancer Research, 2008
- PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesisCellular Signalling, 2007
- Epithelial overexpression of interleukin-32α in inflammatory bowel diseaseClinical and Experimental Immunology, 2007
- The Bcl-2 apoptotic switch in cancer development and therapyOncogene, 2007
- IL-32, a novel cytokine with a possible role in diseaseAnnals of the Rheumatic Diseases, 2006
- Mycobacterium tuberculosis Induces Interleukin-32 Production through a Caspase- 1/IL-18/Interferon-γ-Dependent MechanismPLoS Medicine, 2006
- IL-32: An Emerging Player in the Immune Response Network against Tuberculosis?PLoS Medicine, 2006
- Expression of Transforming Growth Factor β1 (TGFβ1) and Its Receptors in Pancreatic Duct Cell Carcinoma and in Chronic PancreatitisPancreas, 1998
- Mapping of the human BAX gene to chromosome 19q13.3–q13.4 and isolation of a novel alternatively spliced transcript, BAXδGenomics, 1995